PRESAGE BIOSCIENCES, INC.

Basic Information

530 Fairview Avenue North
Seattle, WA, 98109-5553

Company Profile

n/a

Additional Details

Field Value
DUNS: 828848908
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Phase II of VerOFy: A New Tool to Improve Productivity for Stress Research

    Amount: $288,692.00

    DESCRIPTION (provided by applicant): With few exceptions, extensive characterization of signal pathway alterations in cancer, and advances in our capacity to identify potent modulators of distinct mol ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients

    Amount: $1,210,192.00

    DESCRIPTION (provided by applicant): Over 90% of cancer patients that enroll in Phase I or II clinical trials experience no benefit from the experimental therapies, yet are exposed to drug toxicity an ...

    STTR Phase II 2011 Department of Health and Human Services
  3. Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients

    Amount: $164,492.00

    DESCRIPTION (provided by applicant): Over 90% of cancer patients that enroll in Phase I or II clinical trials experience no benefit from the experimental therapies, yet are exposed to drug toxicity an ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government